Literature DB >> 2893546

A linkage and physical map of chromosome 22, and some applications to gene mapping.

C Julier1, G M Lathrop, A Reghis, M F Szajnert, J M Lalouel, J C Kaplan.   

Abstract

A genetic map of human chromosome 22 has been derived from physical assignments and multilocus linkage analysis. It consists of the loci for the immunoglobulin lambda light-chain variable (IGLV) and immunoglobulin lambda light-chain constant (IGLC) regions, myoglobin (MB), the sis proto-oncogene (SIS), and an arbitrary probe (D22S1). The first RFLPs at the loci for SIS, IGLV, and MB are described. The most likely gene order on the basis of multilocus analysis was cen-(IGLV-IGLC)-D22S1-MB-SIS. This map provides further evidence for localization of the P1 polymorphism of the P blood group to chromosome 22, close to the SIS locus. Analysis of families segregating recessive congenital methemoglobinemia (RCM), a disease in which the cytochrome b5 reductase is defective, as well as of families with cases of hereditary low levels of cytochrome b5 reductase activity, confirmed that the locus responsible for RCM is on chromosome 22. Biochemical studies had already suggested that mutation at the cytochrome b5 reductase locus (DIA1) is responsible for RCM. We found no evidence of genetic heterogeneity between the families segregating RCM and the families exhibiting cases of low cytochrome b5 reductase activity. Linkage analysis indicated that the most probable location of DIA1 lies between MB and SIS.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2893546      PMCID: PMC1715259     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  37 in total

1.  Construction of linkage maps with DNA markers for human chromosomes.

Authors:  R White; M Leppert; D T Bishop; D Barker; J Berkowitz; C Brown; P Callahan; T Holm; L Jerominski
Journal:  Nature       Date:  1985 Jan 10-18       Impact factor: 49.962

2.  Report of the Committee on the Genetic Constitution of Chromosomes 20, 21, and 22.

Authors:  P Tippett; J C Kaplan
Journal:  Cytogenet Cell Genet       Date:  1985

3.  The isolation of a human Ig V lambda gene from a recombinant library of chromosome 22 and estimation of its copy number.

Authors:  M L Anderson; M F Szajnert; J C Kaplan; L McColl; B D Young
Journal:  Nucleic Acids Res       Date:  1984-09-11       Impact factor: 16.971

4.  DNA polymorphic loci mapped to human chromosomes 3, 5, 9, 11, 17, 18, and 22.

Authors:  S L Naylor; A Y Sakaguchi; D Barker; R White; T B Shows
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

5.  In situ hybridization and translocation breakpoint mapping. I. Nonidentical 22q11 breakpoints for the t(9;22) of CML and the t(8;22) of Burkitt lymphoma.

Authors:  B S Emanuel; J R Selden; E Wang; P C Nowell; C M Croce
Journal:  Cytogenet Cell Genet       Date:  1984

6.  Nucleotide sequence analysis identifies the human c-sis proto-oncogene as a structural gene for platelet-derived growth factor.

Authors:  I M Chiu; E P Reddy; D Givol; K C Robbins; S R Tronick; S A Aaronson
Journal:  Cell       Date:  1984-05       Impact factor: 41.582

7.  The human myoglobin gene: a third dispersed globin locus in the human genome.

Authors:  A J Jeffreys; V Wilson; A Blanchetot; P Weller; A Geurts van Kessel; N Spurr; E Solomon; P Goodfellow
Journal:  Nucleic Acids Res       Date:  1984-04-11       Impact factor: 16.971

8.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  Linkage of transcobalamin II (TC2) to the P blood group system and assignment to chromosome 22.

Authors:  H Eiberg; N Møller; J Mohr; L S Nielsen
Journal:  Clin Genet       Date:  1986-05       Impact factor: 4.438

10.  The c-sis gene encodes a precursor of the B chain of platelet-derived growth factor.

Authors:  A Johnsson; C H Heldin; A Wasteson; B Westermark; T F Deuel; J S Huang; P H Seeburg; A Gray; A Ullrich; G Scrace
Journal:  EMBO J       Date:  1984-05       Impact factor: 11.598

View more
  9 in total

Review 1.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M R Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

Review 2.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

3.  Isolation of anonymous, polymorphic DNA fragments from human chromosome 22q12-qter.

Authors:  J P Dumanski; A H Geurts van Kessel; M Ruttledge; A Wladis; N Sugawa; V P Collins; M Nordenskjöld
Journal:  Hum Genet       Date:  1990-02       Impact factor: 4.132

4.  Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22.

Authors:  G A Rouleau; B R Seizinger; W Wertelecki; J L Haines; D W Superneau; R L Martuza; J F Gusella
Journal:  Am J Hum Genet       Date:  1990-02       Impact factor: 11.025

5.  Haplotypes of the human immunoglobulin lambda IGLV7S1 and IGLV1S1 genes defined by restriction-site polymorphism and insertion/deletion of a 6-kb DNA fragment.

Authors:  P Chuchana; J P Frippiat; A Blancher; G Lefranc; M P Lefranc
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

6.  A t(4;22) in a meningioma points to the localization of a putative tumor-suppressor gene.

Authors:  R H Lekanne Deprez; N A Groen; N A van Biezen; A Hagemeijer; E van Drunen; J W Koper; C J Avezaat; D Bootsma; E C Zwarthoff
Journal:  Am J Hum Genet       Date:  1991-04       Impact factor: 11.025

7.  Translocation of c-abl oncogene and PDGFB (c-sis) gene in a case of CML with 46,XY, t(22;22).

Authors:  G Gradl; H Tesch; G Schwieder; T Wagner; C Fonatsch
Journal:  Blut       Date:  1989-06

8.  P blood group phenotype, proteus antibody titres, and rheumatoid arthritis.

Authors:  C M Deighton; J Gray; D F Roberts; A J Bint; D J Walker
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

9.  A novel point mutation in a 3' splice site of the NADH-cytochrome b5 reductase gene results in immunologically undetectable enzyme and impaired NADH-dependent ascorbate regeneration in cultured fibroblasts of a patient with type II hereditary methemoglobinemia.

Authors:  K Shirabe; M T Landi; M Takeshita; G Uziel; E Fedrizzi; N Borgese
Journal:  Am J Hum Genet       Date:  1995-08       Impact factor: 11.025

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.